On Mar. 17, 2021, Altasciences working with the National Research Council of Canada (NRC), announced that it had…
On Mar. 16, 2021, Roche announced the launch of the cobas SARS-CoV-2 Variant Set 1 Test to detect…
On Mar. 16, 2021, AstraZeneca announced it had modified an existing agreement with the US Government to supply…
On Mar. 16, 2021, research from the World Health Organization (WHO) and partners showed that the COVID-19 pandemic…
On Mar. 16, 2021, Moderna announced that the first participants had been dosed in the Phase 2/3 study,…
On Mar. 15, 2021, Fulgent Genetics announced that the U.S. Centers for Disease Control and Prevention had awarded…
On Mar. 15, 2021, Resverlogix announced the publishing of a article titled: “Bromodomain and extraterminal protein inhibitor, apabetalone…
On Mar. 15, 2021, ImmunityBio announced it had met the safety requirements for the first 12 participants in…
On Mar. 15, 2021, Twist Bioscience announced that it had started shipping its new synthetic RNA reference controls,…
On Mar. 15, 2021, Moderna announced that the first participants had been dosed in the Phase 1 study…
On Mar. 15, 2021, Altimmune announced additional preclinical data for its single dose intranasal COVID-19 vaccine candidate, AdCOVID….
On Mar. 12, 2021, The World Health Organization (WHO) listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson…
On Mar. 11, 2021, Johnson & Johnson announced that the Committee for Medicinal Products for Human Use (CHMP)…
On Mar. 11, 2021, Johnson & Johnson announced that the European Commission (EC) had granted a Conditional Marketing…
On Mar. 11, 2021, the Israel Ministry of Health (MOH), Pfizer and BioNTech announced real-world evidence demonstrating dramatically…
On Mar. 11, 2021, Abbott announced the formation of the Abbott Pandemic Defense Coalition, a first-of-its-kind global scientific…
On Mar. 11, 2021, Rigel Pharma announced the completion of patient enrollment in a multi-center Phase 2 clinical trial to…
On Mar. 11, 2021, ImmunityBio announced it was developing a novel hAd5 ACE2 Decoy therapeutic vaccine to neutralize…
On Mar. 11, 2021, Altimmune announced that it had expanded its previously-announced AdCOVID manufacturing collaboration with Lonza. Under the…
On Mar. 11, 2021, Novavax announced final efficacy of 96.4% against mild, moderate and severe disease caused by…
On Mar. 10, 2021, the U.S. Department of Defense (DOD) announced that it had identified additional personnel authorized…
On Mar. 10, 2021, The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, announced the start…
On Mar. 10, 2021, XPhyto and 3a-diagnostics announced successful EN ISO 13485 certification for the rapid point-of-care, SARS-CoV-2…
On Mar. 10, 2021, CEPI, the Coalition for Epidemic Preparedness Innovations, and VBI Vaccines announced a partnership to…
On Mar. 10, 2021, Innovation Pharmaceuticals, a clinical stage biopharmaceutical company, is pleased to report that a Machine…
On Mar. 10, 2021, Thermo Fisher Scientific announced more than $600 million in capital investments to expand its…
On Mar. 9, 2021, VBI Vaccines announced the initiation of enrollment of its Phase 1/2 clinical study of…
On Mar. 10, 2021, Luminex announced that it had submitted an Emergency Use Authorization application to the U.S….
On Mar. 9, 2021, PerkinElmer announced the launch of the PerkinElmer COVID-19 Antigen Test for the qualitative detection…
On Mar. 9, 2021, Agilent Technologies announced the launch of a real-time reverse transcription (qRT) PCR-based diagnostic kit…